Neuphoria Therapeutics NEUP
NASDAQ NEUP
$3.59 +0.08 (+2.28%)
As of: Oct 2, 2026 · 9:31 AM EDT

Neuphoria Therapeutics (NEUP) Price to Earnings (2025)

Updated

Neuphoria Therapeutics' Price to Earnings came in at 122.60 for fiscal Q3 2025 (quarter ended Mar 31, 2025).

Analysis

Neuphoria Therapeutics (NEUP) Price to Earnings (2025) Analysis & Trends

For FY2022 (ended Jun 30, 2022), Neuphoria Therapeutics' Price to Earnings was 14459.27.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Neuphoria Therapeutics 443.79 Mn 368.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 122.60
API Access

Neuphoria Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=NEUP&period=max&api_key=YOUR_API_KEY